Literature DB >> 10227072

Sex differences in development of morphine tolerance and dependence in the rat.

R M Craft1, J A Stratmann, R E Bartok, T I Walpole, S J King.   

Abstract

RATIONALE: Several investigators have shown that male rodents are more sensitive than females to morphine's antinociceptive effects.
OBJECTIVE: The present study was conducted to determine whether this sex difference is stable after chronic morphine treatment.
RESULTS: Acutely administered morphine produced significantly greater hotplate and tail withdrawal antinociception in males than in females. In contrast, there were no sex differences in morphine's hotplate or tail withdrawal effects under repeated (1-week interval) dosing conditions. In a separate group of rats, after 2 weeks of twice-daily morphine treatment (10-20 mg/kg per injection), the ED50 for morphine's antinociceptive effects increased approximately 6.9-fold in males versus only 3.7-fold in females; chronic morphine treatment also disrupted the estrous cycle of females. In a separate group of rats treated with 10 mg/kg morphine twice daily for 5 days, treatment with naloxone (1.0 mg/kg) on day 6 produced greater withdrawal scores in males than in females.
CONCLUSIONS: These experiments demonstrate sex differences in development of tolerance to and dependence on morphine in the rat.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227072     DOI: 10.1007/s002130050911

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  Effects of age, but not sex, on elevated startle during withdrawal from acute morphine in adolescent and adult rats.

Authors:  Anna K Radke; Jonathan C Gewirtz; Marilyn E Carroll
Journal:  Behav Pharmacol       Date:  2015-08       Impact factor: 2.293

2.  Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis.

Authors:  Mohit P Chopra; Zachary Feldman; Michael J Mancino; Alison Oliveto
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

3.  Mu-opioid receptor splice variants: sex-dependent regulation by chronic morphine.

Authors:  Vittorio Verzillo; Priyanka A Madia; Nai-Jiang Liu; Sumita Chakrabarti; Alan R Gintzler
Journal:  J Neurochem       Date:  2014-06-11       Impact factor: 5.372

4.  Sex differences in locomotor effects of morphine in the rat.

Authors:  Rebecca M Craft; James L Clark; Stephen P Hart; Megan K Pinckney
Journal:  Pharmacol Biochem Behav       Date:  2007-01-09       Impact factor: 3.533

5.  Phosphorylation of unique C-terminal sites of the mu-opioid receptor variants 1B2 and 1C1 influences their Gs association following chronic morphine.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  J Neurochem       Date:  2019-10-20       Impact factor: 5.372

Review 6.  Sex differences in innate immunity and its impact on opioid pharmacology.

Authors:  Hillary H Doyle; Anne Z Murphy
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

7.  Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake.

Authors:  Anna K Radke; Nathan A Holtz; Jonathan C Gewirtz; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2012-12-20       Impact factor: 4.530

8.  Morphine-enhanced apoptosis in selective brain regions of neonatal rats.

Authors:  Dusica Bajic; Kathryn G Commons; Sulpicio G Soriano
Journal:  Int J Dev Neurosci       Date:  2013-03-07       Impact factor: 2.457

9.  Sex chromosome complement affects nociception in tests of acute and chronic exposure to morphine in mice.

Authors:  Laura Gioiosa; Xuqi Chen; Rebecca Watkins; Nicole Klanfer; Camron D Bryant; Christopher J Evans; Arthur P Arnold
Journal:  Horm Behav       Date:  2007-09-14       Impact factor: 3.587

10.  Sex specificity in methadone analgesia in the rat: a population pharmacokinetic and pharmacodynamic approach.

Authors:  Monica Rodriguez; M Angeles Carlos; Ignacio Ortega; Elena Suarez; Rosario Calvo; John C Lukas
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.